Get More Information on Biosurgery Market - Request Sample Report
The Biosurgery Market was valued at USD 20.11 billion in 2023 and is expected to reach USD 46.20 billion by 2032 and grow at a CAGR of 9.69% over the forecast period 2024-2032.
The growth for the biosurgery market is seen to be very high mainly due to the increasing demand for minimally invasive surgical procedures and the bettering of healthcare technologies. The rising cases of chronic diseases such as cancer, cardiovascular problems, arthritis, and other health issues are presumed to increase the demand for surgical solutions in the coming years. Besides that, the emerging geriatric population, especially in various countries where patients require prolonged medical care and hold a greater tendency to suffer from various diseases, would further enhance the growth of this market.
Underlying growth in the biosurgery market are many factors; among them is an increasing population of geriatrics, increasing heart diseases, and accident and sports injuries. In fact, according to the WHO, injury or violence caused annually accounts for close to 4.4 million deaths, which is 8% of all fatalities. For example, road traffic has been identified as responsible for a third of injury-related deaths; such an approach requires timely effective surgery practice.
Demand for biosurgical products is further driven by innovations in product development and innovative technologies adopted by major market players. Biosurgical products, such as surgical sealants and adhesion barriers, are increasingly being applied to improve the effectiveness of minimally invasive surgeries to reduce intraoperative complications for better patient outcomes. Applying new surgical procedures using newer surgical tools will provide the industry with new opportunities for growth since these products allow surgeons to perform surgical operations more efficiently without increasing surgery-related risks.
In addition, there is a trend toward increasing the use of advanced biosurgery solutions, such as hemostatic agents and surgical sealants, as opposed to traditional sutures and staples for the control of bleeding and wound covering. This trend is driven by increasing attention to effective blood loss management, along with growing numbers of elective surgery procedures that are underpinning an increasing burden of lifestyle-related health issues and an aging population. As severe traumatic injuries start an increase, demand for biosurgical products would, without a doubt go up because people will prefer alternatives to sutures and ligature techniques. Vendors rely more on organic growth strategies like new product launches and developments, enhancing the availability of innovative biosurgical solutions worldwide.
Leading Market Players And Key Products:
|
Company |
Key Biosurgery Products |
Product Type |
|---|---|---|
|
Sanofi |
Fibrin Sealants, Hemostatic Agents |
Hemostatic Agents |
|
Medtronic |
Progel, Peri-Strips Dry |
Surgical Sealants |
|
Baxter |
Tisseel, Floseal |
Hemostatic Agents, Sealants |
|
Johnson & Johnson (Ethicon) |
SURGICEL, EVICEL |
Hemostatic Agents, Fibrin Sealants |
|
Stryker |
Duragen, SurgiWrap |
Adhesion Barriers, Soft Tissue Attachments |
Drivers
Rising Surgical Volumes and Trauma Cases Highlight Need for Adhesion Barriers to Prevent Post-Surgical Complications
An ever-increasing number of surgeries and ever-growing emergencies of critical nature trauma have boosted the demand for adhesion prevention solutions. Adhesion is a widespread complication after surgery that leads to severe health conditions and often requires several additional surgical procedures in the patients. The effects of adhesions post-surgery depend on the type of surgery performed; for instance, it may cause severe abdominal pain after abdominal operations, infertility after gynecological surgery operations, and physical disabilities among neurological surgery patients.
Considering the severe consequences of using such products, such as adhesion barriers, in surgical intervention has, in itself become a serious concern. Adhesion barriers substantially decrease the chances for adhesions to form post-surgery, leading to fewer complications, and therefore excellent patient outcomes. With increasing numbers of surgeries being performed across the globe, such products will become even more important in the future. With hospitals increasingly working towards better management of complications following surgery, adhesion barriers have become an important product in the market, providing a great solution to avoid re-surgery and making patients' recovery more comfortable.
Restraints
The elevated cost of biosurgery products and the increasing expenses associated with surgical procedures
by Product
Surgical sealants were the largest revenue generator for the biosurgery market in the year 2023, holding a share of 26.9%. Most of this growth is to be attributed to the advancements in surgical procedures being performed to address multiple health needs. Surgical sealants are essentially barriers made to prevent leakage of fluids, blood, urine, and air. There are essentially four types of formulations of surgical sealants: fibrin, cyanoacrylates, glutaraldehyde-albumin, and polyethylene glycol-based. Expected to be auguring growth in the years to come are ongoing research and development activities in this segment. For instance, to bridge the therapeutic gap for effective surgical sealants to prevent pulmonary air leaks when the lungs are taken out of the thoracic cavity during surgeries, a new lung-mimetic sealant was developed using material consisting of hydrofoam, a porous ultrastructure, and viscoelastic properties that mimic those of lung tissue, making this an important advancement in surgical sealants.
The segment of soft tissue attachments is expected to grow the fastest in terms of CAGR during the forecast period. This can be attributed to the growing incidence of minimally invasive surgeries, increased road traffic accidents, and a surging increase in the prevalence of chronic diseases. Soft tissue attachments are widely used in orthopedic, dental, oral, plastic, regenerative, reconstructive, and augmentation surgeries. They are used in a wide range of surgical operations, including the repair of tendons, flap procedures, wound healing, dental implants, and GI tract surgeries. The estimated rise in trauma-related injuries, oral infections, and ligament injuries from playing sports and outdoor games would contribute to growth in this segment in the future years. According to the American Association for the Surgery of Trauma, it is estimated that nearly 150,000 people die directly as a result of an injury yearly in the United States, while over 3 million non-fatal injuries take place every year there.
by Application
In the year 2023, the general surgery application segment dominated the global biosurgery market with a 27.5% share. Some of the most common procedures associated with this category are appendectomy, colorectal surgery, endocrine surgery, hernia repair, breast surgeries, vascular surgeries, surgical oncology, trauma surgeries, and more. According to the 2023 ASPS Procedural Statistics Release of the American Society of Plastic Surgeons, breast enhancement surgeries continue to be in demand in aesthetic surgery, wherein breast augmentation procedures increased up to 304,181 for the year 2023, representing a 2% increase over 298,568 procedures for the year 2022. Improved accessibility in trauma care, government programs that encourage affordable general surgeries, and improvement in healthcare infrastructure are mainly expected to trigger enormous growth in this sector for years to come.
The application in cardiovascular surgery is expected to grow at the highest compound annual growth rate (CAGR) between 2024 and 2032. This is due to an increase in the number of patients with cardiovascular diseases, high prevalence of obesity and diabetes, easy accessibility of surgical procedures, improvement in available diagnostic tools and methods, and lifestyle changes that increase the incidence of CVDs. Cardiovascular surgeries are increasingly required because the World Health Organization has identified deaths resulting from cardiovascular diseases as one of the top reasons for death on earth. According to the WHO, the main risk factors that contribute to developing heart disease are continued smoking, bad diets, sedentary lifestyle, and alcohol abuse.
The North American biosurgery market dominated the global landscape in 2023, capturing a substantial revenue share of 50.1%. Key growth drivers include a well-established healthcare infrastructure, increased healthcare spending, and a rising preference for minimally invasive procedures. The high prevalence of chronic diseases such as cancer and heart disease further fuels demand for biosurgery products and procedures, with the U.S. Centers for Disease Control and Prevention noting that a heart attack occurs every 40 seconds in the country.
In Europe, the biosurgery market maintained a significant presence in the global industry, supported by advanced healthcare infrastructure, a skilled surgical workforce, and a growing geriatric population. According to the WHO, the number of individuals aged 60 and older is projected to exceed 300 million by 2050, driving demand for surgical procedures and equipment.
The Asia-Pacific biosurgery market is expected to experience the fastest growth rate, with a CAGR of 6.0% during the forecast period. This growth is primarily driven by rapid economic development in countries like China and India, rising disposable incomes, and improved healthcare infrastructure. An increasing number of trauma-related injuries and cardiovascular disease cases in the region, highlighted by the Economic and Social Commission for Asia Pacific's report of a road accident-related death every 44 seconds, further underpins market expansion. In particular, China's biosurgery market is poised for rapid growth due to its large aging population and rising disease prevalence.
Need Any Customization Research On Biosurgery Market - Inquiry Now
Key Players
Sanofi (Seprafilm (Adhesion Barrier))
Baxter (Tisseel, Hemopatch)
INTEGRA LIFESCIENCES (DuraGen, NeuraGen)
Medtronic (Progel, VenaSeal)
BD (Arista, Progel)
Artivion, Inc (CryoLife, Inc.) (PerClot)
B. Braun SE (TachoSil, Aesculap Bioprosthetic Valves)
Pfizer Inc (Tisseel)
Stryker (Duragen, SurgiWrap)
Johnson & Johnson Services, Inc (SURGICEL, EVICEL)
CSL Ltd. (Beriplast P Combi-Set)
Hemostasis LLC. (Hemostasis)
Orthofix Medical Inc. (Trinity ELITE)
Smiths & Nephew Plc. (REGENETEN)
Kuros Biosciences AG (MagnetOs)
Cyrolife Inc. (PerClot)
B. Braun Melsungen AG (Hemopatch, Aesculap Bioprosthetic Heart Valve), and others.
Recent Developments
In May 2024, Sanofi revealed plans to invest over USD 1.10 billion in biomanufacturing in France, complementing the USD 2.74 billion already committed to significant projects. This investment highlights Sanofi's strategic emphasis on enhancing health sovereignty and aims to bolster its biomanufacturing capabilities within the country.
In November 2023, Ethicon, a Johnson & Johnson MedTech company, received approval for its ETHIZIA Hemostatic sealing patch, specifically designed to effectively manage and halt severe bleeding during surgical procedures. This new hemostatic patch expands Ethicon's extensive biosurgery portfolio, enabling the company to address critical needs in bleeding management.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 20.11 Billion |
| Market Size by 2032 | USD 46.20 Billion |
| CAGR | CAGR of 9.69% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Surgical sealants, Hemostatic agents, Adhesion barriers, Soft Tissue attachments, Bone graft attachments, Others) • By Application (General surgery, Orthopedic surgery, Cardiovascular surgery, Neurological surgery, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia-Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia-Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Sanofi, Baxter, INTEGRA LIFESCIENCES, Medtronic, BD, Artivion, Inc, Braun SE, Pfizer Inc, Stryker, Johnson & Johnson Services, Inc, CSL Ltd., Hemostasis LLC., Orthofix Medical Inc., Smiths & Nephew Plc., Kuros Biosciences AG, Cyrolife Inc., Braun Melsungen AG, and Others |
| Key Drivers | • Rising Surgical Volumes and Trauma Cases Highlight Need for Adhesion Barriers to Prevent Post-Surgical Complications |
| Restraints | • The elevated cost of biosurgery products and the increasing expenses associated with surgical procedures |
The estimated compound annual growth rate is 9.69% during the forecast period for the Biosurgery market.
The projected market value of the Biosurgery market is estimated at USD 20.11 billion in 2023 and is expected to reach USD 46.20 billion by 2032.
Rising surgical volumes and trauma cases highlight the need for adhesion barriers to prevent post-surgical complications.
The elevated cost of biosurgery products and the increasing expenses associated with surgical procedures.
North America is the dominant region with a 50.1% share in the Biosurgery market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, by Region
6.2 Market Share Analysis, by Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Biosurgery Market Segmentation, by Product
Chapter Overview
7.2 Surgical sealants
7.2.1 Surgical Sealants Market Trends Analysis (2020-2032)
7.2.2 Surgical Sealants Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Hemostatic agents
7.3.1 Hemostatic Agents Market Trends Analysis (2020-2032)
7.3.2 Hemostatic Agents Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Adhesion barriers
7.4.1 Adhesion Barriers Market Trends Analysis (2020-2032)
7.4.2 Adhesion Barriers Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Soft Tissue Attachments
7.5.1 Soft Tissue Attachments Market Trends Analysis (2020-2032)
7.5.2 Soft Tissue Attachments Market Size Estimates and Forecasts to 2032 (USD Million)
7.6 Bone graft attachments
7.6.1 Bone Graft Attachments Market Trends Analysis (2020-2032)
7.6.2 Bone Graft Attachments Market Size Estimates and Forecasts to 2032 (USD Million)
7.7 Others
7.7.1 Others Market Trends Analysis (2020-2032)
7.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
8. Biosurgery Market Segmentation, by Application
Chapter Overview
8.2 General surgery
8.2.1 General Surgery Market Trends Analysis (2020-2032)
8.2.2 General Surgery Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Orthopedic surgery
8.3.1 Orthopedic Surgery Market Trends Analysis (2020-2032)
8.3.2 Orthopedic Surgery Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Cardiovascular surgery
8.4.1 Cardiovascular Surgery Market Trends Analysis (2020-2032)
8.4.2 Cardiovascular Surgery Market Size Estimates and Forecasts to 2032 (USD Million)
8.5 Neurological surgery
8.5.1 Neurological Surgery Market Trends Analysis (2020-2032)
8.5.2 Neurological Surgery Market Size Estimates and Forecasts to 2032 (USD Million)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.2.3 North America Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.4 North America Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.5.2 USA Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.6.2 Canada Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.7.2 Mexico Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.1.3 Eastern Europe Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.4 Eastern Europe Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.1.5 Poland
9.3.1.5.1 Poland Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.5.2 Poland Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.1.6 Romania
9.3.1.6.1 Romania Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.6.2 Romania Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.7.2 Hungary Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.8.2 Turkey Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.1.9.2 Rest of Eastern Europe Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.2.3 Western Europe Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.4 Western Europe Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.5 Germany
9.3.2.5.1 Germany Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.5.2 Germany Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.6 France
9.3.2.6.1 France Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.6.2 France Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.7 UK
9.3.2.7.1 UK Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.7.2 UK Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.8 Italy
9.3.2.8.1 Italy Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.8.2 Italy Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.9 Spain
9.3.2.9.1 Spain Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.9.2 Spain Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.10.2 Netherlands Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.11.2 Switzerland Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.12 Austria
9.3.2.12.1 Austria Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.12.2 Austria Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.3.2.13.2 Rest of Western Europe Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.4.3 Asia Pacific Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.4 Asia Pacific Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.5 China
9.4.5.1 China Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 China Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.6 India
9.4.5.1 India Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 India Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.5.2 Japan Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.6.2 South Korea Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.7 Vietnam
9.4.7.1 Vietnam Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.2.7.2 Vietnam Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.8 Singapore
9.4.8.1 Singapore Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.8.2 Singapore Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.9 Australia
9.4.9.1 Australia Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.9.2 Australia Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.4.10.2 Rest of Asia Pacific Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.1.3 Middle East Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.4 Middle East Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.1.5 UAE
9.5.1.5.1 UAE Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.5.2 UAE Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.6.2 Egypt Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.7.2 Saudi Arabia Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.8.2 Qatar Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.1.9.2 Rest of Middle East Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.2.3 Africa Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.4 Africa Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.5.2 South Africa Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.5.2.6.2 Nigeria Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Biosurgery Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.6.3 Latin America Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.4 Latin America Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.5.2 Brazil Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.6.2 Argentina Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.6.7 Colombia
9.6.7.1 Colombia Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.7.2 Colombia Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Biosurgery Market Estimates and Forecasts, by Product (2020-2032) (USD Million)
9.6.8.2 Rest of Latin America Biosurgery Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10. Company Profiles
10.1 Sanofi
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Services/ Services Offered
110.1.4 SWOT Analysis
10.2 Baxter
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Services/ Services Offered
10.2.4 SWOT Analysis
10.3 INTEGRA LIFESCIENCES
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Services/ Services Offered
10.3.4 SWOT Analysis
10.4 Medtronic
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Services/ Services Offered
10.4.4 SWOT Analysis
10.5 Pfizer
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Services/ Services Offered
10.5.4 SWOT Analysis
10.6 Stryker
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Services/ Services Offered
10.6.4 SWOT Analysis
10.7 Hemostasis LLC.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Services/ Services Offered
10.7.4 SWOT Analysis
10.8 Orthofix Medical Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Services/ Services Offered
10.8.4 SWOT Analysis
10.9 Smiths & Nephew Plc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Services/ Services Offered
10.9.4 SWOT Analysis
10.10 B. Braun Melsungen AG
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Services/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Product
Surgical sealants
Hemostatic agents
Adhesion barriers
Soft Tissue attachments
Bone graft attachments
Others
By Application
General surgery
Orthopedic surgery
Cardiovascular surgery
Neurological surgery
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Online Pharmacy Market size was valued at USD 112.88 billion in 2023 and is estimated to reach USD 399.10 Billion by 2031 and grow at a CAGR of 17.1% over the forecast period of 2024-2031.
The Erectile Dysfunction Treatment Drugs Market was valued at USD 3.31 billion in 2023 and is expected to reach USD 5.97 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.84% from 2024 to 2032.
The Fluoroscopy Imaging Systems Market Size was valued at USD 1.99 billion in 2023 and is expected to reach USD 2.45 billion by 2032 and grow at a CAGR of 2.37% over the forecast period 2024-2032.
The Irritable Bowel Syndrome Treatment Market Size was valued at USD 1.47 billion in 2022, and is expected to reach USD 2.81 billion by 2030, and grow at a CAGR of 8.4% over the forecast period 2023-2030.
The Venous Thromboembolism Treatment Market Size was valued at USD 1.05 Bn in 2023, and is expected to reach USD 2.13 Bn by 2032, and grow at a CAGR of 8.50% Over the Forecast Period of 2024-2032.
The Tissue Diagnostics Market Size was valued at USD 6.83 billion in 2023 and is expected to reach USD 14.18 billion by 2032 and grow at a CAGR of 8.47% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
